Next Article in Journal
Comparative Evaluation of Booster Vaccine Efficacy by Intracoelomic Injection and Immersion with a Whole-Cell Killed Vaccine against Lactococcus petauri Infection in Rainbow Trout (Oncorhynchus mykiss)
Next Article in Special Issue
Epidemiology of Blastocystis Infection: A Review of Data from Poland in Relation to Other Reports
Previous Article in Journal
Establishment of a Simple and Rapid Nucleic Acid Detection Method for Hookworm Identification
Previous Article in Special Issue
Risk Factors and the Character of Clinical Course of the Echinococcus multilocularis Infection in Patients in Poland
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

The Immunological Changes in the Skin of BALC/c Mice with Disseminated Acanthamoebiasis

by
Agnieszka Wojtkowiak-Giera
1,
Monika Derda
1,*,
Natalia Łanocha-Arendarczyk
2,
Agnieszka Kolasa
3,
Karolina Kot
2,
Joanna Walczykiewicz
1,
Piotr Solarczyk
1 and
Danuta Kosik-Bogacka
4
1
Department of Biology and Medical Parasitology, Poznan University of Medical Sciences, 60-781 Poznan, Poland
2
Department of Biology and Medical Parasitology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland
3
Department of Histology and Embryology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland
4
Independent of Pharmaceutical Botany, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland
*
Author to whom correspondence should be addressed.
Submission received: 25 March 2023 / Revised: 19 April 2023 / Accepted: 20 April 2023 / Published: 22 April 2023

Abstract

:
Toll-like receptors (TLR) are involved in the recognition of numerous pathogens, including Acanthamoeba spp. Thanks to this, it is possible for immune cells to recognize microorganisms and trigger the body’s innate immune response. The stimulation of TLRs also leads to the activation of specific immunity. The aim of the study was to determine the TLR2 and TLR4 gene expression in the skin of BALC/c mice infected with Acanthamoeba with AM22 strain isolated from a patient. Receptor expression was assessed by real-time polymerase chain reaction (qPCR) in the amoeba-infected host with normal (A) and reduced immunity (AS) as well as in the control host with normal immunity (C) and reduced immunity (CS). Statistical analysis of TLR2 gene expression in A and AS groups compared to C and CS groups, respectively, were statistically insignificant. In the A group, we found statistical upregulation of TLR4 gene expression at 8 dpi compared to the C group. While in AS group, TLR4 gene expression was at a similar level, such as in the CS group. Taking into account the host’s immune status, the TLR4 gene expression was statistically higher in the skin of host from A group than in host from AS group at the beginning of the infection. Increased TLR4 gene expression in hosts with normal immunity infected with Acanthamoeba suggests the involvement of the studied receptor in the course of acanthamoebiasis. The above research results provide new data on the involvement of the studied receptor in the skin in the host’s immune defense triggered during the Acanthamoeba infection.

1. Introduction

Free-living amoebae of the genus Acanthamoeba are cosmopolitan protozoans and pathogenic strains that may cause infections in the brain (granulomatous amoebic encephalitis, GAE), eye (Acanthamoeba keratitis, AK), lungs and skin. Cutaneous amoebiasis (CA) is a rare opportunistic infection; primary skin amoebic changes as well as cutaneous lesions from disseminated amoebiasis are much more common in patients with immunodeficiency disorders, including patients with an HIV infection and patients on immunosuppressive therapy with or without CNS involvement [1]. Risk factors for Acanthamoeba skin lesions include traumatized areas, such as surgical scars, viral lesions, bites and mechanical trauma [2,3]. Acanthamoeba spp. skin infections may be the manifestation of an infection that is initiated in another organ and spreads hematogenously or are the primary focus of infection through skin wounds that posteriorly spread to other tissues [4]. As the first observed symptom of skin Acanthamoeba spp. infection wound inflammation develops, it results in skin changes [5]. Cutaneous acanthamoebiasis can present variable lesions, including papules, pustules, nodules and skin ulcers that contain Acanthamoeba trophozoites and cysts. Some authors observed that Acanthamoeba inducted skin tissue necrosis [6,7,8,9].
Toll-like receptors (TLRs) are a family of protein-transmembrane receptors. TLR2 and TLR4 are the most extensively investigated members of the family. Our earlier studies confirmed changes in the expression of TLR2 and TLR4 in organs, such as kidneys, heart and eyes of mice infected with Acanthamoeba. Therefore, we selected the same receptors to examine in the skin of immunocompetent and immunosuppressed mice post-Acanthamoeba spp. infection [10,11,12,13]. Additionally, TLR4 is the receptor that stimulates the pathways of TLR4-MyD88-NF-κB and TLR4-ERK1/2 and activates inflammatory cytokines in acanthamoebiasis [7,14,15]. As well, TLR plays an important role in directing the T helper cell (Th) differentiation during amoeba infection [16].
These receptors induce the production of inflammatory mediators after recognition of pathogen-associated molecular patterns (PAMP) or host-derived damage-associated molecular patterns (DAMPs) [17,18,19].
One of the first described receptors in this family was TLR2 (transmembrane protein) which recognizes a wide variety of ligands. The best-known ligands in parasites, such as Trypanosoma cruzi, T. brucei, Plasmodium falciparum, Toxoplasma gondii, Leishmania donovani and L. major are glycosylphosphatidylinositol (GPI) anchors and lysophosphatidylserine found in Schistosoma mansoni [20,21,22,23,24]. In addition, TLR2 shows the ability to form complexes with the receptor TLR1 and TLR6, which increase the range of recognized ligands [25]. The second extracellular receptor, of which the best-known ligand is LPS (lipopolysaccharide), present in the cell wall of Gram-negative bacteria is TLR4. Other ligands include heat shock protein (HSP60, HSP70 and Cp96) and lipophosphoglycan (LPG) found in Leishmania spp., lysophosphatidylserine, present in Schistosoma spp., lipophosphoglycan in L. major, lipopeptidophosphoglycan in Entamoeba histolytica, phospholipid in Ascaris lumbricoides [26,27,28,29,30] and GPI occurring in Plasmodium falciparum, Toxoplasma gondii and T. cruzi [31].
The signal transduction process occurs as a result of contact with pathogens and recognition of different ligands by TLRs. The adapter proteins involved in this process are TIRAP (TIR-domain-containing protein), TRIF (TIR-domain-containing adapter inducing INF-β), TRAM (TRIF-related adapter molecule) and MyD88 (myeloid differentiation factor 88). The signal transduction can be divided into two pathways: protein Myd88 dependent and independent [32]. The protein MyD88 is involved in TLR2-mediated signaling in the cell which binds to the receptor via the protein adapter TIRAP. This is followed by the activation of IRAK-4 and autophosphorylation of IRAK-1 which is released from the complex with the receptor and binds to the TRAF-6 factor [33]. In the next step, the complex TAK-1-TAB activates kinases (IKK and IKKβ) and stimulates transcription factor NF-κB, stimulating the expression of proinflammatory cytokines, such as IL-6, IL-10 and TNF-α [34].
In the case of TLR4 signaling transduction, there is the participation of two protein adapters, MyD88 and TRIF. The pathway with the TRIF protein adapter requires involvement of the second protein adapter, TRAM. This connects two adapter-activated kinases TBK1 (TANK-Binding Kinase-1) and IKKε/IKKi. The next step is the activation of the transcription factor IRF3 which stimulates interferon I gene expression and the production of interleukins, such as IL-1, Il-6, Il-8, Il-12 and Il-18 [31,35,36]. The signal transduction is also affected by the protein Tollip (Toll interacting protein). This protein acts as an IRAk-1 kinase to block its action [37].
No studies to date have addressed the implications of the role of TLR-2 and TLR-4 in the skin of immunocompetent and immunosuppressed mice post Acanthamoeba spp. infection. Thus, to clarify the role of Toll-like receptors in the skin from Acanthamoeba infected host in relation to the immune status, the goal of this study was to determine (by two different methods, such as quantitative real time and immunohistochemistry) whether Acanthamoeba spp. may affect the expression and activity of Toll-like receptors in the skin.

2. Material and Methods

2.1. The Design of Experimental Model of Disseminate Acanthamoebiasis

The design of the experiment (mouse infection and animal immunosuppression) has been described in detail in our previous works [10,38]. Briefly, Balb/c mice (n = 96) were used in all experiments, and procedures were approved by Local Ethics Committee for Experiments on Animals in Szczecin (No. 29/2015, dated 22 June 2015) and Poznań (No. 64/2016, dated 9 September 2016). All efforts were made to minimize mice suffering.
The Acanthamoeba spp. trophozoites (AM 22 strain, genotype T16) used for the experimental infection were obtained from the bronchoaspirate of the patient [39]. Male mice were grouped into four groups as follows: A, amoeba-infected host with normal immunity (n = 30); AS, amoeba-infected host with reduced immunity induced by MPS, methylprednisolone sodium succinate (n = 30); C, control host with normal immunity (n = 18); CS, control host with reduced immunity induced by MPS (n = 18). For four days before amoeba infection, mice from AS and CS groups were intraperitoneally administered MPS (10 mg/kg in 0.1 mL of 0.9% NaCl) (Solu-Medrol, Pfizer, Puurs, Belgium, Europe), an anti-inflammatory glucocorticoid with immunosuppressive properties according to the methodology described by Markovitz et al. (1978) [40]. Animals from groups A and AS were intranasally given 3 μL of a suspension of Acanthamoeba trophozoites containing 10,000–20,000 of the amoebae counted in the Bürker chamber. Mice from the C and CS groups received 3 μL of 0.9% NaCl (dropped on the mouse’s nose). At different time points after infection (8, 16, 24 days post-infection, dpi), mice were euthanized with a peritoneal overdose of sodium pentobarbital (Euthasol vet, FATRO) (2 mL/kg body weight) to obtain tissues that were adequately secured.
The mice were subjected to daily observation. Twenty-four infected animals with dermatological changes, including alopecia, thinning and tousled fur and coat color changes were qualified for the study of immune mechanisms occurring in the skin; 12 mice from both A and AS groups and 5 mice from both C and CS groups (total n = 34) qualified. During the autopsy, skin sections (2 cm × 2 cm) were taken from the upper left part of the mouse’s back. The skin was shaved, divided into two sections, and then preserved for histological examination in 4% formalin and for biochemical-immunological studies at −80 °C, respectively [41].
The scheme of the experiment is presented in Figure 1.

2.2. Quantitative Real-Time PCR (qPCR)

TLR2 and TLR4 gene expression in the skin of mice in different groups was measured by qPCR (performed on a Light Cycler instrument from Roche Diagnostic GmbH, Mannheim, Germany) as described previously [11,12].
Briefly, SYBR Green I was used for detection dye, the housekeeping gene PBGD (porphobilinogen deaminase) as the reference gene for mRNA quantification and two tested TLR genes were examined and presented below as primers. The amounts of TLR2 and TLR4 transcripts in each sample were determined by the geometric means of the transcript level of the housekeeping gene, and finally, the relative level of expression of the two tested genes was calculated on the basis of the E-method formula (Roche Diagnostic).
In this study the following primers were used:
TLR2 [13]
5′-AAA GAT GTC GTT CAA GGA GG-3′
5′-ATT TGA CGC TTT GTC TGA GG-3′
TLR4 [13]
5′-TTC TTC TCC TGC CTG ACA CC-3′
5′-CTT TGC TGA GTT TCT GAT CCAT-3′
PBGD [13]
5′-TGG ACC TAG TGA GTG TGT TG-3′
5′-GGT ACA GTT GCC CAT CTT TC 3′

2.3. Immunohistochemistry

The dissected samples of skin (sample size about 1 cm3, localization: thigh skin, number n = 5 from each group: C, A, AS and CS) were fixed in 4% formalin (Chempur, Poland) for at least 24 h and then washed with absolute ethanol (Standlab, Poland; 3 times over 3 h), absolute ethanol with xylene (Supelco, Merck, Germany; 1:1; twice over 1 h) and xylene (3 times over 20 min). Then, after 3 h of saturation of the tissues in liquid paraffin, the samples were embedded in paraffin blocks. Using a microtome (Microm HM340E), 3–5 μm serial sections were taken and placed on polysine microscope slides (Thermo Scientific, UK). The sections of the skin were deparaffinized in xylene and rehydrated in decreasing concentrations of ethanol and microwaved in citrate buffer (pH 6.0) to induce epitope retrieval. After slow cooling to room temperature, slides were washed in PBS twice for 5 min and then incubated with primary antibodies overnight (4 °C). Immunohistochemistry was performed using specific primary rabbit polyclonal antibodies against TLR2 and TLR4 (Santa Cruz Biotechnology, Inc., Dallas, TX, USA; cat. no. sc-10739 and sc-30002, respectively) in a final 1:500 dilution, after checking and standardized other recommended by manufacturer concentrations from 1:50 to 1:500. Sections were stained with an avidin-biotin-peroxidase system with diaminobenzidine as the chromogen (Dako Envision +Dual Link System- HRP (DAB+) and performed according to staining procedure instructions included. Sections were washed in distilled H2O and counterstained with hematoxylin. The IHC reaction with 1:500 concentrated antibodies was performed 3 times. For negative control, specimens were processed in the absence of primary antibodies. For positive control, samples of spleen were immunostained as described above. Positive staining of the skin sample was defined by visual identification of brown pigmentation using a light microscope (Leica, DM5000B, Wetzlar, Germany). The samples were independently examined by two experienced histologists. The score of immunoexpression was conducted according to immunoreactivity based on visual examination of intensity and is as follows: negative (−), almost negative (+/−), weak positive (+), moderate positive (++) and strong positive (+++).

2.4. Statistical Analysis

Statistical analysis was carried out using StatSoft Statistica v.10.0. Initially, the Shapiro–Wilk test was performed which revealed whether the distribution of the data followed a normal distribution. Since the data did not follow a normal distribution then nonparametric tests were used for statistical analysis. The Mann–Whitney U test was used to compare two groups, and the Kruskal–Wallis H test was used to compare three groups. A statistical significance point of p < 0.05 was adopted. GraphPad 4.0 software was used to create graphs.

3. Results

3.1. TLR2 and TLR4 Genes Expression

Statistical analysis of TLR2 gene expression in different time points in A and AS groups were statistically insignificant (H = 4.26, p = 0.24 and H = 5.44, p = 0.14, respectively). TLR2 gene expression was at similar levels in the A group at all time points and the C group. In the amoeba-infected hosts with reduced immunity group (AS), we found upregulation of TLR2 gene expression at 8 dpi compared to the CS group. The difference turned out to be statistically insignificant, probably due to the large standard deviation in the AS 8 dpi group. In the AS 16 and 24 dpi groups, gene expression was at a level similar to CS group. It was also shown that immune status did not affect the TLR2 gene expression (A vs AS) (Figure 2).
The TLR4 gene expression at different time points in A and AS groups was statistically insignificant (H = 6.55, p = 0.09 and H = 0.08, p = 0.99, respectively). In the amoeba-infected host with normal immunity group (A), we found statistical upregulation of the TLR4 gene expression at 8 dpi compared to the C group (U = 1.00, p < 0.05). In AS 16 and 24 dpi groups gene expression was at a level similar to C group. In the amoeba-infected host with reduced immunity (AS), we noted that TLR4 gene expression was at a similar level in the AS group at all time points and CS group. Taking into account the host’s immune status, the TLR4 gene expression was statistically higher in the skin of amoeba-infected mice with normal immunity (A) than in amoeba-infected hosts with reduced immunity (AS) at the beginning of the infection (Figure 3).

3.2. Results of Immunohistochemistry

Immunoexpression of TLR2 in the skin of uninfected immunocompetent mice (Figure 4A) was visible in some areas of connective tissue of the dermis (red arrow) and in some keratinocytes of the epidermis (white arrow); this expression was at a moderate/low level. After eight days following the Acanthamoeba spp. Infection, the level of immunoreactivity for TLR2 became higher (Figure 4C, red arrows), and gradually on the following days post-Acanthamoeba spp. infection it became lower (Figure 4E,G) and was visible only in the deeper connective tissue of the dermis or near the epidermis (red arrows).
Immunoexpression of the TLR2 skin of uninfected immunosuppressed mice (Figure 4B, red arrows) was much lower than in the immunocompetent control (Figure 4A). After Acanthamoeba spp. infection of immunocompetent mice, the level of these receptors slightly increased in the first week after Acanthamoeba spp. infection (Figure 4D, red arrows) and became similar to the uninfected immunocompetent mice at 16 and 24 dpi (Figure 4F,H, red arrows).
In the skin of uninfected immunocompetent mice, the immunoexpression of TLR4 (Figure 4I) is very weak and mainly located just under the epidermis (red arrows). In uninfected immunosuppressed mice skin (Figure 4J), TLR4-expression was higher than in immunocompetent mice, and it was visible in the deeper layer of connective tissue of the dermis, just near some hair follicles (red arrows). Similarly, TLR4 expression increased at the beginning of Acanthamoeba spp. infection (Figure 4K, red arrows), and then gradually became much lower (Figure 4M,O, red arrows) and very similar to uninfected immunocompetent mice (Figure 4I). The level of TLR4 immunoexpression in the skin of Acanthamoeba spp. infected immunosuppressed mice regardless of the duration of the infection was similar (Figure 4L–P, red arrows) to the level of uninfected immunosuppressed animals (Figure 4J).

4. Discussion

This study aimed to investigate, to our knowledge for the first time, the expression of TLR2 and TLR4 in skin immunocompetent and immunosuppressed mice post-Acanthamoeba spp. infection. These studies showed change (but not statistically significant) in the expression of TLR2 in uninfected and Acanthamoeba spp. Infected mice according to immunological status. However, we observed that TLR4 expression was significantly upregulated in the skin at eight days post-Acanthamoeba spp. infection in an immunocompetent host. The important thing for our studies was the expression of TLR4 in the immunocompetent host (significantly higher at eight days post Acanthamoeba infection) and immunoexpression of TLR4 in the skin (the area of connective tissue of the dermis) were observed on the same day. Our results were confirmed by two different methods (qPCR and immunohistochemistry) that TLR4 is stimulated in response to Acanthamoeba spp. infection in the skin problems. In our previous study, Kot et al. in the kidneys noted a higher TLR2 expression in immunosuppressed mice at 24 day post Acanthamoeba spp. infection, similarly in the heart there was upregulation but in immunocompetent mice [10]. In the eye, increased expression of TLR2 and TLR4 in immunocompetent mice was observed at eight, sixteen and twenty-four days post-Acanthamoeba spp. infection, but immunosuppressed mice showed significant differences in the expression of TLR2 at 16 and 24 dpi [11]. In the lungs of immunocompetent Acanthamoeba spp.-infected mice, it was observed that TLR2 expression was higher than TLR4 expression, and the expression of TLR2 and TLR4 was increased from two to thirty days post-Acanthamoeba spp. infection [13]. In brain immunocompetent mice, Acanthamoeba spp. infection was observed as having increased expression of TLR2 and TLR4 at the beginning of infection [12].
The study of Ordeix et al. confirmed the expression of TLR2 receptors in large mononuclear cells in the skin of dogs infected with Leishmania infantum [42]. Similarly, studies by Pereira-Fonseca et al. confirmed the higher expression of TLR2 and TNF-α in dogs infected with Leishmania [43]. In a study, Polari et al. demonstrated higher expression of TLR2 and TLR4 in monocytes in human cutaneous leishmaniasis (Leishmania braziliensis) [44]. Furthermore, higher expression of TLR2 and TLR4 was confirmed in experiments by Campos et al. in cutaneous leishmaniasis (Leishmania braziliensis and Leishmania amazonensis) [45]. In this study, TLR 2 and TLR4 expression was visible in the deeper layer of connective tissue of the dermis mice Acanthamoeba spp. infected.
Cutaneous acanthamoebiasis is a disease that is difficult to diagnose. Moreover, there is no effective method of treatment of this pathogen, and despite the use of complex mixed long-term therapies, it may result in the patient’s death [46]. So far, it is not clear whether Acanthamoeba is the direct cause of the skin symptoms, or whether they are a consequence of the amoeba’s presence in other organs [47]. The results presented by Hernandez-Jasso et al. showed that the skin of Acanthamoeba-infected mice exposed to UV-B radiation is a source of infection from which trophozoites can travel by blood to other organs [4]. Other results indicated that patient treatment with immunosuppressants after kidney transplantation led to the development of painful nodules on the skin [6]. This case confirmed that cutaneous acanthamoebiasis is present frequently in patients treated with immunosuppressants.
The skin is the first barrier in the contact with pathogens and is an important element of the non-specific defense reaction; therefore, the presence of TLRs in the skin and their roles are very interesting subjects for scientific research [47].
TLRs have been implicated in the pathogenesis of skin diseases, such as atopic dermatitis and psoriasis. The molecules have been shown to be important in cutaneous host defense mechanisms against common bacterial, fungal and viral pathogens in the skin [48]. TLR2 mediates the innate immune response to bacterial pathogens and induces Th1 cytokine secretion. TLR2 was differentially expressed at several time points, and most highly downregulated in crusted scabies at the beginning of infection [49]. The relationship between TLRs and skin Acanthamoeba spp. infection remains relatively unknown.
Clinical observations confirm that primary cutaneous acanthamoebiasis has a different outcome and prognosis depending on whether there is CNS involvement. In patients without CNS involvement, the onset of amoebic skin changes is acute to subacute, with multiple lesions continually developing. Conversely, patients with brain Acanthamoeba spp. infection generally develop cutaneous lesions as a late manifestation of systemic disease which carries a very poor prognosis and is almost universally fatal [50]. In this study, we used a strain with neurophilic effects where numerous amoeba trophozoites were re-isolated from brain fragments from Acanthamoeba spp.-infected immunocompetent and immunosuppressed mice [38].
In summary, our study confirmed for the first time the change in expression of TLR4 in the skin of mice infected with Acanthamoeba in immunocompetent hosts. TLR4 is upregulated in the skin of immunocompetent mice in response to Acanthamoeba spp. at the beginning of the invasion. Further understanding of the mechanism of action of this receptor may lead to the discovery of a new method of prevention and effective treatment of acanthamoebiasis.

Author Contributions

Conceptualization, A.W.-G.; Methodology: A.W.-G., J.W., A.K., K.K., N.Ł.-A., P.S. and D.K.-B.; statistical analysis, D.K.-B.; writing—original draft preparation, A.W.-G., J.W., A.K., K.K., N.Ł.-A., D.K.-B. and P.S.; writing—response to reviewers and final version, A.W.-G.; M.D.; Visualization, N.Ł.-A. and A.K., Supervision, M.D.; Funding Acquisition, M.D. and D.K.-B. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the statutory funds of the Department of Biology and Medical Parasitology, Poznan University of Medical Sciences and The Pomeranian Medical University in Szczecin provided financial support (WFB-431-02/S/12/2022).

Institutional Review Board Statement

The present study was approved by the Local Ethics Committee for Scientific Experiments on Animals in Szczecin (No. 29/2015 of 22 June 2015) and Poznań (No. 64/2016 of 9 September 2016). All animal experiments were performed in strict agreement with good animal practice with the recommendations in the Guide for Care and Use of Laboratory Animals.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Reddy, D.L.; van den Berg, E.; Grayson, W.; Mphahlele, M.; Frean, J. Clinical improvement of disseminated Acanthamoeba infection in a patient with advanced HIV using a non-miltefosine-based treatment regimen in a low-resource setting. Trop. Med. Infect. Dis. 2022, 7, 24. [Google Scholar] [CrossRef]
  2. Galarza, C.; Ramos, W.; Gutierrez, E.L.; Ronceros, G.; Teran, M.; Uribe, M.; Ñavincopa, M.; Ortega-Loayza, A.G. Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients. Int. J. Dermatol. 2009, 48, 1324–1329. [Google Scholar] [CrossRef]
  3. Król-Turmińska, K.; Olender, A. Human infections caused by free-living amoebae. Ann Agric. Environ. Med. 2017, 24, 254–260. [Google Scholar] [CrossRef]
  4. Hernández-Jasso, M.; Hernández-Martínez, D.; Avila-Acevedo, J.G.; Benítez-Flores, J.D.C.; Gallegos-Hernández, I.A.; García-Bores, A.M.; Espinosa-González, A.M.; Villamar-Duque, T.E.; Castelan-Ramírez, I.; González-Valle, M.D.R.; et al. Morphological description of the early events during the invasion of Acanthamoeba castellanii trophozoites in a murine model of skin irradiated under UV-B Light. Pathogens 2020, 27, 794. [Google Scholar] [CrossRef]
  5. Padzik, M.; Hendiger, E.B.; Szaflik, J.P.; Chomicz, L. Pełzaki z rodzaju Acanthamoeba-czynniki etiologiczne stanów patologicznych ludzkiego organizmu. Post. Mikrobiol. 2017, 56, 429–439. [Google Scholar]
  6. Winsett, F.; Dietert, J.; Tschen, J.; Swaby, M.; Bangert, C.A. A rare case of cutaneous acanthamoebiasis in a renal transplant patient. Dermatol. Online J. 2017, 23, 1–4. [Google Scholar] [CrossRef]
  7. Ren, M.Y.; Wu, X.Y. Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba keratitis. Parasite Immunol. 2011, 33, 25–33. [Google Scholar] [CrossRef]
  8. Feng, X.; Zheng, W.; Wang, Y.; Zhao, D.; Jiang, X.; Lv, S. A rabbit model of acanthamoeba keratitis that better reflects the natural human infection. Anat. Rec. 2015, 298, 1509–1517. [Google Scholar] [CrossRef] [PubMed]
  9. Füst, Á.J.; Tóth, J.; Simon, G.; Imre, L.; Nagy, Z.Z. Specificity of in vivo confocal cornea microscopy in Acanthamoeba keratitis. Eur. J. Ophthalmol. 2017, 27, 10–15. [Google Scholar] [CrossRef]
  10. Kot, K.; Kosik-Bogacka, D.; Wojtkowiak-Giera, A.; Kolasa-Wołosiuk, A.; Łanocha-Arendarczyk, N. The expression of TLR2 and TLR4 in the kidneys and heart of mice infected with Acanthamoeba spp. Parasit. Vectors. 2020, 13, 1–11. [Google Scholar] [CrossRef]
  11. Kot, K.; Kosik-Bogacka, D.; Łanocha-Arendarczyk, N.; Wojtkowiak-Giera, A.; Kolasa-Wołosiuk, A. Expression of Toll-like receptors (TLR2 and TLR4) in the eyes of mice with disseminated acanthamoebiasis. Biomed. Res. Int. 2019, 2019, 14001894. [Google Scholar] [CrossRef]
  12. Wojtkowiak-Giera, A.; Derda, M.; Kolasa-Wołosiuk, A.; Hadaś, E.; Kosik-Bogacka, D.; Solarczuk, P.; Jagodziński, P.P.; Wandurska-Nowak, E. Toll-like receptors in the brain of mice following infection with Acanthamoeba spp. Parasitol. Res. 2016, 115, 4335–4344. [Google Scholar] [CrossRef] [PubMed]
  13. Derda, M.; Wojtkowiak-Giera, A.; Kolasa-Wołosiuk, A.; Kosik-Bogacka, D.; Hadaś, E.; Jagodziński, P.P.; Wandurska-Nowak, E. Acanthamoeba infection in lungs of mice expressed by toll-like receptors (TLR2 and TLR4). Exp. Parasitol. 2016, 165, 30–34. [Google Scholar] [CrossRef] [PubMed]
  14. Alizadeh, H.; Tripathi, T.; Abdi, M.; Smith, A.D. Pathogenic strains of Acanthamoeba are recognized by TLR4 and initiated inflammatory responses in the cornea. PLoS ONE 2014, 9, e92375. [Google Scholar] [CrossRef] [PubMed]
  15. Ren, M.; Gao, L.; Wu, X. TLR4: The receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines. Immunol. Cell Biol. 2010, 88, 529–536. [Google Scholar] [CrossRef] [PubMed]
  16. Grygorowicz, M.A.; Kozłowska, E. Involvement of receptors recognizing pathogen-associated molecular patterns—TLRs in modulation of regulatory T cell CD4 +CD25 +FoxP3 + activity. Postepy Mikrobiologii 2011, 50, 141–154. [Google Scholar]
  17. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783–801. [Google Scholar] [CrossRef]
  18. Roach, J.C.; Glusman, G.; Rowen, L.; Kaur, A.; Purcell, M.K.; Smith, K.D.; Hood, L.E.; Aderem, A. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. USA 2005, 102, 9577–9582. [Google Scholar] [CrossRef]
  19. Kawai, T.; Akira, S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 2009, 21, 317–337. [Google Scholar] [CrossRef]
  20. Krishnegowda, G.; Hajjar, A.M.; Zhu, J.; Douglass, E.J.; Uematsu, S.; Akira, S.; Woods, A.S.; Gowda, D.C. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: Cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 2005, 280, 8606–8616. [Google Scholar] [CrossRef]
  21. Debierre-Grockiego, F.; Campos, M.A.; Azzouz, N.; Schmidt, J.; Bieker, U.; Resende, M.G.; Mansur, D.S.; Weingart, R.; Schmidt, R.R.; Golenbock, D.T.; et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J. Immunol. 2007, 179, 1129–1137. [Google Scholar] [CrossRef] [PubMed]
  22. Chandra, D.; Naik, S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineale by modylating MAPK pathways through a contact-dependent mechanizm. Clin. Exp. Immunol. 2008, 154, 224–234. [Google Scholar] [CrossRef]
  23. Egan, C.E.; Sukhumavasi, W.; Butcher, B.A.; Denkers, E.Y. Functional aspekt of Toll-like receptor/myd88 signalling turing protozoan iInfection: Focus on Toxoplasma gondii. Clin. Exp. Immunol. 2009, 156, 17–24. [Google Scholar] [CrossRef] [PubMed]
  24. Amin, D.N.; Vodnala, S.K.; Masocha, W.; Sun, B.; Kristensson, K.; Rottenberg, M.E. Distinct Toll-like receptor signals regulate cerebral parasite load and Interferon α/ß and tumor necrosis factor α-dependent T-cell infiltration in the brains of Trypanosoma brucei—Infected mice. J. Infect. Dis. 2012, 205, 320–332. [Google Scholar] [CrossRef]
  25. Tartey, S.; Takeuchi, O. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells. Int. Rev. Immunol. 2017, 36, 57–73. [Google Scholar] [CrossRef]
  26. Palsson-McDermott, E.M.; O’Neill, L.A. Signal transduction by lipopolysaccharide receptor, Toll-like receptor-4. Immunolog. 2004, 113, 153–162. [Google Scholar] [CrossRef] [PubMed]
  27. Tuon, F.F.; Amato, V.S.; Bacha, H.A.; Almusawi, T.; Duerte, M.I.; Neto, V.A. Toll-like receptors and leishmaniasis. Infect. Immun. 2008, 76, 866–872. [Google Scholar] [CrossRef]
  28. van der Kleij, D.; Latz, E.T.N.F.; Brouwers, J.F.; Kruize, Y.C.; Schmitz, M.; Kurt-Jones, E.A.; Espevik, T.; de Jong, E.C.; Kapsenberg, M.L.; Golenbock, D.T.; et al. A Novel host-parasite lipid cross-talk. schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 2002, 277, 48122–48129. [Google Scholar] [CrossRef]
  29. Layland, L.E.; Rad, R.R.; Wagner, H.; da Costa, C.U. Immunopathology in Schistosomiasis is controlled by antygen-specific regulatory T-cells primed in the presence of TLR2. Eur. J. Immunol. 2007, 37, 2174–2184. [Google Scholar] [CrossRef]
  30. van der Kleij, D.; van den Biggelaar, A.H.; Kruize, Y.C.; Retra, K.; Fillie, Y.; Schmitz, M.; Kremsner, P.G.; Tielens, A.G.; Yazdanbakhsh, M. Responses to Toll-like receptor ligands in children living in areas where Schistosome infections are endemic. J. Infect. Dis. 2004, 189, 1044–1051. [Google Scholar] [CrossRef]
  31. Mukherjee, S.; Karmakar, S.; Babu, S.P. TLR2 and TLR4 mediated host immune responses in major infectious diseases: A review. Braz. J. infect. Dis. 2016, 20, 193–204. [Google Scholar] [CrossRef]
  32. Satoh, T.; Akira, S. Toll-like receptor signaling and its inducible proteins. Microbiol. Spectr. 2016, 4, 1–7. [Google Scholar] [CrossRef]
  33. Jończyk, M.; Kuliczkowska-Płaksej, J.; Mierzwicka, A.; Bolanowski, M. The polycystic oovaria syndrome and chronic inflommation: The role of Toll-like receptors. Postepy High. Med. Dosw. 2018, 72, 1199–1207. [Google Scholar] [CrossRef]
  34. Hug, H.; Mohajeri, M.H.; La Fata, G. Toll-Like Receptors: Regulators of the immune response in the human gut. Nutrients. 2018, 10, 203. [Google Scholar] [CrossRef] [PubMed]
  35. Gołąb, J.; Jakubisiak, M.; Lasek, W. Immunologia; Wydawnictwo Naukowe PWN: Warszawa, Poland, 2002. [Google Scholar]
  36. Czerkies, M.; Kwiatkowska, K. Receptory Toll-podobne (TLR) i ich udział we wrodzonej odpowiedzi odpornościowej na przykładzie aktywacji TLR4 przez lipopolisacharyd. Postępy Biol. Komórki. 2013, 40, 39–64. [Google Scholar]
  37. Majewska, M.; Szczepanik, M. The role of toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation. Postępy Hig. Med. Dosw. 2006, 60, 52–63. [Google Scholar]
  38. Łanocha-Arendarczyk, N.; Baranowska-Bosiacka, I.; Kot, K.; Gutowska, I.; Kolasa-Wołosiuk, A.; Chlubek, D.; Kosik-Bogacka, D. Expression and activity of COX-1 and COX-2 in Acanthamoeba sp.-infected lungs according to the host immunological status. Int. J. Mol. Sci. 2018, 19, 121. [Google Scholar] [CrossRef]
  39. Łanocha, N.; Kosik-Bogacka, D.; Kuźna-Grygiel, W. Rola pełzaków wolno-żyjących w wywoływaniu i transmisji chorób u ludzi i zwierząt. Probl. Hig. Epidemiol. 2009, 90, 165–170. [Google Scholar]
  40. Markowitz, S.M.; Sobieski, T.; Martinez, A.J.; Duma, R.J. Experimental Acanthamoeba infections in mice pretreated with methylprednisolone or tetracycline. Am. J. Pathol. 1978, 92, 733–744. [Google Scholar]
  41. Kot, K.; Kosik-Bogacka, D.; Łanocha-Arendarczyk, N.; Ptak, M.; Roszkowska, P.; Kram, A. Histological changes in the kidneys and heart in experimental acanthamoebiasis in immunocompetent and immunosuppressed hosts. Folia Biol. 2021, 69, 167–178. [Google Scholar] [CrossRef]
  42. Ordeix, L.; Silva, J.E.D.S.; Llull, J.; Quirola, P.; Montserrat-Sangra, S.; Martinez-Orellana, P.; Solano-Gallego, L. Histological and immunological description of the leishmanian skin test in Ibizan hounds. J. Comp. Pathol. 2018, 158, 56–65. [Google Scholar] [CrossRef]
  43. Pereira-Fonseca, D.C.M.; Oliviera-Rovai, F.M.; Rodas, L.A.C.; Beloti, C.A.C.; Torrecilha, R.B.P.; Ito, P.K.R.K.; Avanco, S.V.; Cipriano, R.S.; Utsunomiya, Y.T.; Hiramoto, R.M.; et al. Dog skin parasite load, TLR-2. IL-10 and TNF-α expression an infectiousness. Parasite Immunol. 2017, 39, e12493. [Google Scholar] [CrossRef] [PubMed]
  44. Polari, L.P.; Carneiro, P.P.; Macedo, M.; Machado, P.R.L.; Scott, P.; Carvalho, E.M.; Bacellar, O. Leishmania braziliensis enhances Toll-like recptors 2 and 4 expression and triggers TNF-α and IL-10 production in human cutaneous leishmaniasis. Front. Cell Infect. Microbiol. 2019, 9, 1–11. [Google Scholar] [CrossRef]
  45. Campos, M.B.; Lima, L.V.D.R.; de Lima, A.C.S.; Vasconcelos Dos Santos, T.; Ramos, P.K.S.; Gomes, C.M.C.; Silveira, F.T. Toll-like receptors 2, 4 and 9 expressions over the en tire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania (V.) braziliensis and Leishmania (L.) amazonensis. PloS ONE 2018, 13, e0194383. [Google Scholar] [CrossRef] [PubMed]
  46. Gromczyńska, G.; Szymańska-Pomorska, G.; Pytel, A. Pełzakowate zapalenie rogówki jako powikłanie nieprawidłowego używania soczewek kontaktowych. Kosmetologia Estetyczna. 2015, 5, 503–508. [Google Scholar]
  47. Bossowska, M.; Dembele, K.; Toka, F.N. Udział receptorów Toll-podobnych w patogenezie atopowego zapalenia skóry u ludzi i zwierząt. Część II. Atopowe zapalenie skóry—Charakterystyka, występowanie i objawy choroby. Życie Wet. 2016, 91, 31–35. [Google Scholar]
  48. Miller, L.S. Toll-like receptors in skin. Adv. Dermatol. 2008, 24, 71–87. [Google Scholar] [CrossRef]
  49. Bhat, S.A.; Walton, S.F.; Ventura, T.; Liu, X.; McCarthy, J.S.; Burgess, S.T.G.; Mounsey, K.E. Early immune suppression leads to uncontrolled mite proliferation and potent host inflammatory responses in a porcine model of crusted versus ordinary scabies. PLoS Negl. Trop. Dis. 2020, 4, e000860. [Google Scholar] [CrossRef]
  50. Morrison, A.O.; Morris, R.; Shannon, A.; Lauer, S.R.; Guarner, J.; Kraft, C.S. Disseminated Acanthamoeba infection presenting with cutaneous lesions in an immunocompromised patient: A case report, review of histomorphologic findings, and potential diagnostic pitfalls. Am. J. Clin. Pathol. 2016, 145, 266–270. [Google Scholar] [CrossRef]
Figure 1. Schematic illustration of disseminated acanthamoebiasis experiment. Hosts were divided into two groups depending on their immunological status. Firstly, for four days before amoeba infection, mice assigned to AS and CS group were given methylprednisolone sodium succinate (MSP) for immunosuppression. Then, A and AS groups were inoculated the Acanthamoeba spp. trophozoites. After 8, 16 and 24 days post-infection (dpi), the mice were euthanized and the shaved skin samples were collected for analysis A, amoeba-infected host with normal immunity (n = 30); AS, amoeba-infected host with reduced immunity induced by MPS, methylprednisolone sodium succinate (n = 30); C, control host with normal immunity (n = 18); CS, control host with reduced immunity induced by MPS (n = 18). Original photos.
Figure 1. Schematic illustration of disseminated acanthamoebiasis experiment. Hosts were divided into two groups depending on their immunological status. Firstly, for four days before amoeba infection, mice assigned to AS and CS group were given methylprednisolone sodium succinate (MSP) for immunosuppression. Then, A and AS groups were inoculated the Acanthamoeba spp. trophozoites. After 8, 16 and 24 days post-infection (dpi), the mice were euthanized and the shaved skin samples were collected for analysis A, amoeba-infected host with normal immunity (n = 30); AS, amoeba-infected host with reduced immunity induced by MPS, methylprednisolone sodium succinate (n = 30); C, control host with normal immunity (n = 18); CS, control host with reduced immunity induced by MPS (n = 18). Original photos.
Pathogens 12 00631 g001
Figure 2. The TLR2 gene expression in the skin of control and amoeba-infected mice at 8, 16 and 24 dpi, (A, amoeba-infected host with normal immunity; AS, amoeba-infected host with reduced immunity induced by MPS, methylprednisolone sodium succinate; C, control host with normal immunity; CS, control host with reduced immunity induced by MPS). In the graph arithmetic mean ± standard deviation was shown; p < 0.05.
Figure 2. The TLR2 gene expression in the skin of control and amoeba-infected mice at 8, 16 and 24 dpi, (A, amoeba-infected host with normal immunity; AS, amoeba-infected host with reduced immunity induced by MPS, methylprednisolone sodium succinate; C, control host with normal immunity; CS, control host with reduced immunity induced by MPS). In the graph arithmetic mean ± standard deviation was shown; p < 0.05.
Pathogens 12 00631 g002
Figure 3. The TLR4 gene expression in the skin of control and amoeba-infected mice at 8, 16 and 24 dpi, (A, amoeba-infected hosts with normal immunity; AS, amoeba-infected hosts with reduced immunity induced by MPS, methylprednisolone sodium succinate; C, control hosts with normal immunity; CS, control hosts with reduced immunity induced by MPS). In the graph, arithmetic mean ± standard deviation was shown; p < 0.05; black arrow, difference between A vs. C; dotted arrow, difference between A vs. AS.
Figure 3. The TLR4 gene expression in the skin of control and amoeba-infected mice at 8, 16 and 24 dpi, (A, amoeba-infected hosts with normal immunity; AS, amoeba-infected hosts with reduced immunity induced by MPS, methylprednisolone sodium succinate; C, control hosts with normal immunity; CS, control hosts with reduced immunity induced by MPS). In the graph, arithmetic mean ± standard deviation was shown; p < 0.05; black arrow, difference between A vs. C; dotted arrow, difference between A vs. AS.
Pathogens 12 00631 g003
Figure 4. Representative microphotography that shows immunoexpression of TLR2 (AH) and TLR4 (IP) in skin of immunocompetent and immunosuppressed uninfected mice (0 dpi) and at 8, 16, and 24 days after Acanthamoeba spp. infection (dpi). Immunohistochemical reaction with diaminobenzidine (DAB) as a chromogen. Objective magnification 40×. Red arrows mark the area of connective tissue of dermis where immunoexpression of Toll-like receptors 2 (TLR2) and 4 (TLR4) was visible as brown pigmentation; white arrows mark the keratinocytes of epidermis where immunoexpression of TLR2 was visible as brown pigmentation. Abbreviation: C—uninfected immunocompetent mice (n = 5), CS—uninfected immunosuppressed mice (n = 5), A—immunocompetent Acanthamoeba spp. infected mice (n = 5), AS—immunosuppressed Acanthamoeba spp. infected mice (n = 5).
Figure 4. Representative microphotography that shows immunoexpression of TLR2 (AH) and TLR4 (IP) in skin of immunocompetent and immunosuppressed uninfected mice (0 dpi) and at 8, 16, and 24 days after Acanthamoeba spp. infection (dpi). Immunohistochemical reaction with diaminobenzidine (DAB) as a chromogen. Objective magnification 40×. Red arrows mark the area of connective tissue of dermis where immunoexpression of Toll-like receptors 2 (TLR2) and 4 (TLR4) was visible as brown pigmentation; white arrows mark the keratinocytes of epidermis where immunoexpression of TLR2 was visible as brown pigmentation. Abbreviation: C—uninfected immunocompetent mice (n = 5), CS—uninfected immunosuppressed mice (n = 5), A—immunocompetent Acanthamoeba spp. infected mice (n = 5), AS—immunosuppressed Acanthamoeba spp. infected mice (n = 5).
Pathogens 12 00631 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wojtkowiak-Giera, A.; Derda, M.; Łanocha-Arendarczyk, N.; Kolasa, A.; Kot, K.; Walczykiewicz, J.; Solarczyk, P.; Kosik-Bogacka, D. The Immunological Changes in the Skin of BALC/c Mice with Disseminated Acanthamoebiasis. Pathogens 2023, 12, 631. https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens12050631

AMA Style

Wojtkowiak-Giera A, Derda M, Łanocha-Arendarczyk N, Kolasa A, Kot K, Walczykiewicz J, Solarczyk P, Kosik-Bogacka D. The Immunological Changes in the Skin of BALC/c Mice with Disseminated Acanthamoebiasis. Pathogens. 2023; 12(5):631. https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens12050631

Chicago/Turabian Style

Wojtkowiak-Giera, Agnieszka, Monika Derda, Natalia Łanocha-Arendarczyk, Agnieszka Kolasa, Karolina Kot, Joanna Walczykiewicz, Piotr Solarczyk, and Danuta Kosik-Bogacka. 2023. "The Immunological Changes in the Skin of BALC/c Mice with Disseminated Acanthamoebiasis" Pathogens 12, no. 5: 631. https://0-doi-org.brum.beds.ac.uk/10.3390/pathogens12050631

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop